Mononuclear subsets and cytokine profile of venous and capillary blood in patients with psoriasis and healthy people

Psoriasis is considered an autoimmune disease with a predominantly cellular mechanism for the development of disorder. Studies in immune pathogenesis of psoriasis were performed either in animal model, which is not just similar to humans, or the data were obtained in patients by means of skin window method, which is traumatic, or by examining venous blood. However, it is difficult to discern parameters of the local immune response in venous blood samples. We have attempted to find an adequate method which would be convenient both for the patient and for the researcher, in order to assess local immune processes occurring in the skin affected by psoriasis. We examined 20 patients with a verified diagnosis of psoriasis, the average age was 44.3 years. The control group included 15 healthy adults, with average age of 46.6 years. Capillary blood was taken by fingerprick, whereas, in psoriatic patients, the samples were taken near the psoriatic lesion at a final volume of 400 μL in two microvettes. Venous blood (3 mL) was taken from the cubital vein into a vacuum tube with EDTA. Clinical analysis of venous and capillary blood was performed in automated hematological analyzer. Immunophenotyping was performed by four-color staining of whole capillary and venous blood followed by lysis of erythrocytes. Cytofluorometry was performed using techniques and reagents from BD Biosciences (USA). Plasma cytokines were determined by multiplex approach (MagPix, BioRad, USA). Upon clinical analysis of blood, the difference between capillary and venous blood was not found, either in healthy group, or among patients with psoriasis. In healthy people, the subsets of mononuclear cells, did not differ between venous and capillary blood. The samples of capillary and venous blood in the patients with psoriasis showed significantly increased levels of double-positive lymphocytes (CD45RA+/CD45R0+), B lymphocytes and NKT lymphocytes (both for relative and and absolute values). A significant increase in the percentage of naive T lymphocytes, activated helpers (Thact) and Treg, as well as B1 cells and Breg, and a significant decrease in B2 lymphocytes was registered in capillary blood of the patients with psoriasis. In venous blood samples from psoriatic patients, only a significant increase in Thact, Treg, and Breg was revealed. In the capillary blood of patients with psoriasis, we found a significant increase in the levels of non-classical M2 monocytes and inflammatory Minfl monocytes, and a decrease in classical M1 monocyte levels; in venous blood of psoriatic patients, only an increase in inflammatory Minfl monocytes was revealed. In capillary blood, all the studied cytokines in psoriasis patients significantly exceeded the levels of corresponding cytokines in healthy controls, except of IL-10. The levels of this cytokine did not differ from healthy group. In venous blood, the levels of most studied cytokines in the group of patients with psoriasis did not differ from the group of healthy ones. Approximately two-fold increase was revealed for IL-4, IL-21, IL-23 and TNF. First, the subsets of mononuclear cells and the cytokine profile of capillary and venous blood of healthy people did not differ significantly. Secondly, our proposed method for determining the subsets of mononuclear cells and capillary blood cytokines profile from the area of psoriatic lesions may be used to monitor local immunity in the patients with psoriasis. This approach is significantly less traumatic than the skin window method and more informative than the studies of venous blood.

1. Sennikova S.V., Toptygina A.P. Interleukin-36 family as a novel regulator of inflammation in the barrier tissues. Meditsinskaya immunologiya = Medical Immunology (Russia), 2020, Vol. 22, no. 1, pp. 49-60. (In Russ.)] doi: 10.15789/1563-0625-IFA-1880.

2. Khaydukov S.V., Baydun L.A., Zurochka A.V., Totolian Areg A. Standardized technology “Research of lymphocytes subpopulation composition in peripheral blood using flow cytometry analyzers” (Draft). Meditsinskaya immunologiya = Medical Immunology (Russia), 2012, Vol. 14, no. 3, pp. 255-268. (In Russ.)] doi: 10/15789/1563-0625-2012-3-255-268.

3. Batycka-Baran A., Maj J., Wolf R., Szepietowski J.C. The new insight into the role of antimicrobial proteinsalarmins in the immunopathogenesis of psoriasis. J. Immunol. Res., 2014, Vol. 2014, e.628289. doi: 10.1155/2014/628289.

4. Boehncke W.H., Schön M.P. Psoriasis. Lancet, 2015, Vol. 386, no. 9997, pp. 983-994.

5. Buckner J.H. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol, 2010, Vol. 10, no. 12, pp. 849-859.

6. Buchau A.S., Gallo R.L. Innate immunity and antimicrobial defense systems in psoriasis. Clin. Dermatol., 2007, Vol. 25, no. 6, pp. 616- 624.

7. Carrier Y., Ma H.L., Ramon H.E., Napierata L., Small C., O’Toole M., Young D.A., Fouser L.A., NickersonNutter C., Collins M., Dunussi-Joannopoulos K., Medley Q.G. Inter-regulation of th17 cytokines and the il-36 cytokines in vitro and in vivo: Implications in psoriasis pathogenesis. J. Invest. Dermatol., 2011, Vol. 131, no. 12, pp. 2428-2437.

8. Chiricozzi A., Romanelli P., Volpe E., Borsellino G., Romanelli M. Scanning the immunopathogenesis of psoriasis. Int. J. Mol.Sci., 2018, Vol. 19, no. 1, 179. doi: 10.3390/ijms19010179.

9. Davidson A., Diamond B. Autoimmune diseases. N. Engl. J. Med., 2001, Vol. 345, no. 5, pp. 340-350.

10. di Marco M., Schuster H., Backert L.,Ghosh M., Rammensee H.G., Stevanovic S. Unveiling the peptide motifs of HLA-C and HLA-G fromnaturally presented peptides and generation of binding prediction matrices. J. Immunol., 2017, Vol. 199, no. 8, pp. 2639-2651.

11. Elias P.M., Arbiser J., Brown B.E., Rossiter H., Man M.Q., Cerimele F., Crumrine D., Gunathilake R., Choi E.H., Uchida Y., Tschachler E., Feingold K.R. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am. J. Pathol., 2008, Vol. 173, no. 3, pp. 689-699.

12. Fitch E., Harper E., Skorcheva I., Kurtz S.E., Blauvelt A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr. Rheumatol. Rep., 2007, Vol. 9, no. 6, pp. 461-467.

13. Garcia-Rodriguez S., Arias-Santiago S., Perandrés-López R., Castellote L., Zumaquero E., Navarro P., Buendía-Eisman A., Ruiz J-C., Orgaz-Molina J., Sancho J., Zubiaur M. Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis. J. Eur. Acad. Dermatol. Venereol., 2013, Vol. 27, no. 2, pp. 242-250.

14. Goodman W.A., Cooper K.D., McCormick T.S. Regulation generation: the suppressive functions of human regulatory T cells. Crit. Rev. Immunol., 2012, Vol. 32, no. 1, pp. 65-79.

15. González-Parra S., Daudén E. Psoriasis and Depression: The Role of Inflammation. Actas Dermo-sifiliogr (Engl Ed.), 2019, Vol. 110, no. 1, pp. 12-19.

16. Gregorio J., Meller S., Conrad C., Di Nardo A., Homey B., Lauerma A., Arai N., Gallo R.L., Digiovanni J., Gilliet M. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med., 2010, Vol. 207, no. 13, pp. 2921-2930.

17. Gladman D. D., Antoni C., Mease P., Clegg D.O., Nash, P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann. Rheum Dis., 2005, Vol. 64, Suppl. 2, pp. ii14-ii17.

18. Gottlieb A.B., Chamian F., Masud S., Cardinale I., Abello M.V., Lowes M.A., Chen F., Magliocco M., Krueger J.G. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J. Immunol., 2005, Vol. 175, no. 4, pp. 2721-2729.

19. Hegyi Z., Zwicker S., Bureik D., Peric M., Koglin S, Batycka-Baran A., Prinz J. C., Ruzicka T., Schauber J., Wolf R. Vitamin D analog calcipotriol suppresses the Th17 cytokineinduced proinflammatory S100 “alarmins” psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J. Invest. Dermatol., 2012, Vol. 132, no. 5, pp. 1416-1424.

20. Katayama H. Development of psoriasis by continuous neutrophil infiltration into the epidermis. Eхp. Dermatol., 2018, Vol. 27, no. 10, pp. 1084-1091.

21. Langley R.G.B., Krueger G.G., Griffiths C.E.M. Psoriasis: epidemiology, clinical features, and quality of life. Ann. Rheum. Dis., 2005, Vol. 64, Suppl. 2, pp. 18-23.

22. Lee E.B., Wu K.K., Lee M.P., Bhutani T., Wu J.J. Psoriasis risk factors and triggers. Cutis, 2018, Vol. 102, no. 5S, pp. 18-20.

23. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., P BowmanE.M., Krueger J.G.Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol., 2008, Vol. 128, no. 5, pp. 1207-1211.

24. Lu J., Ding Y., Yi X., Zheng J. CD19+ B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity. Braz. J. Med. Biol. Res., 2016, Vol. 49, no. 9, e5374. doi: 10.1590/1414-431X20165374.

25. Man X.Y., Yang X.H., Cai S.Q., Bu Z.Y., Zheng M. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF. J. Cell. Mol. Med., 2008, Vol. 12, no. 2, pp. 649-660.

26. Mattei P.L., Corey K.C., Kimball A.B. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J. Eur. Acad. Dermatol. Venereol., 2014, Vol. 28, no. 3, pp. 333-337.

27. Matsushita T. Regulatory and effector B cells: Friends or foes? J. Dermatol. Sci., 2019, Vol. 93, no. 1, pp. 2-7.

28. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., Burg G., Liu Y.J., Gilliet M. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med., 2005, Vol. 202, no. 1, pp. 135-143.

29. Pochernina V.V., Daschuk A.M. TLR expression on peripheral blood monocytes in patients with psoriasis. Wiad Lek., 2020, Vol. 73, no. 2, pp. 401-404.

30. Piskin G., Sylva-Steenland R.M.R., Bos J.D., Teunissen M.B.M. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol., 2006, Vol. 176, no. 3, pp. 1908-1915.

31. Santini S.M., Lapenta C., Donati S., Spadaro F., Belardelli F., Ferrantini M. Interferon-α-conditioned human monocytes combine a TH1-orienting attitude with the induction of autologous TH17 responses: role of IL-23 and IL-12. PLoS One, 2011, Vol. 6, no. 2, e17364. doi: 10.1371/journal.pone.0017364.

32. Schadler E.D., Ortel B., Mehlis S.L.Biologics for the primary care physician: Review and treatment of psoriasis. Dis. Mon., 2019, Vol. 65, no. 3, pp. 51-90.

33. Tauber M., Bal E., Pei X-Y., Madrange M., Khelil A., Sahel H., Zenati A., Makrelouf M., Boubridaa K., Chiali A., Smahi N., Otsmane F., Bouajar B., Marrakchi S., Turki H., Bourrat E., Viguier M., Hamel Y., Bachelez H., Smahi A. IL36RN Mutations Affect Protein Expression and Function: A Basis for Genotype-Phenotype Correlation in Pustular Diseases. J. Invest. Dermatol., 2016, Vol. 136, no. 9, pp. 1811-1819.

34. van der Vliet H.J., von Blomberg B.M., Nishi N., Reijm M., Voskuyl A.E., van Bodegraven A.A., Polman C.H., Rustemeyer T., Lips P., van den Eertwegh A .J., Giaccone G., Scheper R.J., Pinedo H.M. Circulating Va24+ Vb11+NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol., 2001, Vol. 100, no. 2, pp. 144-148.

35. Wanga A., Bai Y.P. Dendritic cells: The driver of psoriasis. J. Dermatol., 2020, Vol. 47, no. 2, pp. 104-113.

36. Wang C.Q.F., Akalu Y.T., Suarez-Farinas M., Gonzalez J., Mitsui H., Lowes M.A., Orlow S.J., Manga P., Krueger J.G. IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J. Invest. Dermatol., 2013, Vol. 133, no. 12, pp. 2741-2752.

37. World Health Organization. Global report on psoriasis. Available at: https://apps.who.int/iris/handle/10665/204417 (last accessed 20 July 2021).

38. Young H.S., Summers A.M., Bhushan M., Brenchley P.E.C., Griffiths C.E.M. Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J. Invest. Dermatol., 2004, Vol. 122, no. 1, pp. 209-215.

39. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., Ouyang W. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature, 2007, Vol. 445, no. 7128, pp. 648-651.